What is Lassa fever and what are the symptoms after UK case
A person with Lassa fever – which can cause Ebola-like illness in some people – travelled to England at the end of February, it has been announced.
The UK Health Security Agency (UKHSA) said it had been informed under international rules that a person travelled to England from Nigeria while they were unwell with Lassa fever.
They then returned to Nigeria where they were diagnosed, it said.
The UKHSA is now 'working to identify people who were in contact with the affected individual while they were in the country'.
What is Lassa fever?
Lassa fever is an acute viral haemorrhagic illness, belonging to the virus family Arenaviridae, that lasts between two and 21 days, according to the World Health Organisation (WHO).
The virus, for which there is no approved vaccine, is known to be endemic in Benin, Ghana, Guinea, Liberia, Mali, Sierra Leone, and Nigeria.
But it also probably exists in other West African countries as well.
What are the symptoms?
After starting as a fever with aches and pains, the symptoms can progress to headache, vomiting and diarrhoea.
Severe cases can cause victims to bleed from the mouth and nose.
How is it transmitted and is it easy to catch?
Humans can contract Lassa fever from eating food that has been tainted by the urine or faeces of rodents.
The virus, like Ebola, can also be spread through contact with the bodily fluids of a sick person, but it does not spread easily between humans.
According to the WHO, there is no epidemiological evidence supporting airborne spread from person to person.
How deadly is Lassa fever?
Most people with Lassa fever will make a full recovery although severe illness can occur.
The overall case-fatality rate is 1 per cent, according to the WHO.
But the observed case-fatality rate among patients who are admitted to hospital with severe cases of Lassa fever is 15 per cent.
Early supportive care with rehydration and symptomatic treatment improves survival chances.
How many cases have there been in the UK?
Lassa fever cases are rare in the UK. Since 1971, there have been 13 confirmed cases of Lassa fever reported in the UK. All were linked to travel or were travel associated, according to the UKHSA.
The last known incident was in February 2022 when a confirmed case, with recent travel to Mali, was reported. The person later died. Two further cases linked to this were subsequently detected.
What is the risk to the public?
The UKHSA said the risk to the public 'remains very low'.
It is 'working to identify people who were in contact with the affected individual while they were in the country'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
17 hours ago
- Daily Record
'Distinct' signs of latest Covid-19 Nimbus variant including 'razor blade throat'
The UK has seen a rise in Covid-related hospital admissions by almost 10 per cent in the last week of May The UK is grappling with the rise of a new Covid strain known as Nimbus or NB. 1.8.1. Britain has seen an increase of almost 10 per cent in Covid-related hospital admissions in the final week of May amid cautions from the World Health Organisation (WHO). The novel strain is marked by a harrowing "razor blade throat" symptom that mimics the feeling of blades scraping your throat with every swallow — sufferers are urged to seek rest, liquids and pain relief. Dr Naveed Asif of The London General Practice told the Independent about the unique nature of this sore throat, labelling it "distinctive" for those struck by Nimbus. On top of that, the NHS advises anyone suspecting they've caught Covid to self-isolate. Echoing NHS guidance, the UKHSA warns: "If you have symptoms of a respiratory infection, such as Covid-19, and you have a high temperature or do not feel well enough to go to work or carry out normal activities, you should avoid contact with vulnerable people and stay at home if possible." Speaking on the latest Covid symptoms, Doctor Mohamed Imran Lakhi of Prescription Doctor's said: 'People commonly report a severe sore throat, persistent fatigue, mild cough, fever, muscle aches, and nasal congestion. "Some also experience digestive issues like nausea or diarrhoea, which isn't always typical with Covid variants.' For those living with Covid and seeking further advice, including when self-isolation isn't viable, visit the website, reports the Mirror. Initially detected in January, the Nimbus variant has since taken a global stage. Nimbus has become the prevalent variant in China and constitutes a third of US cases, and is currently energising a fresh uptick in Australian infections. A recent preprint study suggests that the so-called Nimbus variant of Covid-19 may bind to human cells more effectively, potentially allowing for easier transmission and the ability to dodge immunity from previous infections. This research on Nimbus is awaiting peer review, but already the World Health Organisation has assured that current vaccines remain potent against this strain. As reported by Salon, there are no indications that Nimbus is tied to increased illness severity in comparison with other variants. University of Guelph's Dr. T. Ryan Gregory told Salon: "That said, we learned from Omicron that high transmissibility can cause as much damage as high per infection virulence and at this point it is not just acute severity that is of concern, but longer-term impacts of repeated infection." Dr. Gregory added that spotting symptoms unique to Nimbus could be tough due to the mixing of various strains and less testing compared to peak pandemic periods. Furthermore, Dr Gayatri Amirthalingam of UKHSA recently declared: "NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid cases. "Based on the available information so far however, there is no evidence to suggest that this variant causes more severe disease than previous variants, or that the vaccines in current use will be less effective against it."
Daily Record
20 hours ago
- Daily Record
UKHSA urges UK tourists to act 'at least' four weeks before flying
Advice comes following "concerning levels" in certain imported illnesses Experts have urged Brits gearing up for an overseas holiday to tick off one task "at least" four weeks before their departure. The vital step could be essential for your health and well-being during your travels. The UK Health Security Agency (UKHSA) has advised travellers to seek medical help ahead of international trips. This is necessary to check if any vaccinations or medications are necessary for the intended destination. These consultations should are needed "four to six weeks" prior to the holiday, as per UKHSA guidelines. The agency said: "Ideally travellers should consult their GP, practice nurse, pharmacist, or travel clinic at least four to six weeks before their trip for individual advice, travel vaccines and malaria prevention tablets, if relevant for their destination." Additionally, it's imperative for holidaymakers to: Keep routine childhood immunisations current Obtain all suggested travel-related vaccines Obtain sufficient stocks of essential medicines, including antimalarials Acquire comprehensive travel insurance that covers the full duration of the trip and all planned activities This guidance is issued amid reports showing a surge in travel-associated enteric fever instances (including typhoid and paratyphoid fevers) across England, Wales, and Northern Ireland. The year 2024 saw 702 reported cases, marking an eight per cent increase from the 645 cases registered in 2023. "This represents the highest number of cases recorded annually to date," stated the UKHSA. A free typhoid jab is accessible at GP surgeries for certain travellers, although there's no existing vaccine for paratyphoid. Furthermore, imported malaria cases persist at "concerning levels" in the UK, despite a slight dip in diagnoses to 1,812 in 2024 from 2,106 in 2023. "These figures significantly exceed the levels seen in recent years," the UKHSA reported. Malaria - prevention and where it is often found Malaria, while potentially lethal, can be almost entirely prevented with the correct use of antimalarial tablets. If you're aware that your destination country has a malaria problem, you can obtain these tablets from a GP, nurse, pharmacist or travel clinic prior to your departure. Malaria is mainly found in tropical areas including: Large areas of Africa and Asia Central and South America Dominican Republic and Haiti Parts of the Middle East Some Pacific islands Doctor Philip Veal, a public health consultant at UKHSA, said: "We are seeing high levels of infections such as malaria and typhoid in returning travellers. It is important that travellers remain alert and plan ahead of going abroad – even if you're visiting friends and relatives abroad or it's somewhere you visit often. "The Travel Health Pro website provides information on how to maintain your health and that of your family, including which vaccines to get, any essential medication such as anti-malaria tablets, and how to avoid gastrointestinal infections such as typhoid and hepatitis A. If you are pregnant or trying to conceive there are special precautions you should take, so please speak to a healthcare professional before planning your trip."
Daily Mirror
20 hours ago
- Daily Mirror
'Razor blade throat' and other key signs of Nimbus COVID variant
The NB.1.8.1 variant may have some symptoms that other Covid strains don't cause The UK has reported cases of the new Covid variant, Nimbus or NB. 1.8.1, with a rise in Covid-related hospital admissions by almost 10% in the last week of May, following a warning from the World Health Organisation (WHO). Sufferers of the new variant have described a "razor blade throat" symptom. This reportedly feels like blades scratching the back of your throat every time you swallow. A very painful symptom and those suffering from it have been advised to get rest, fluids and painkillers to manage the condition. Dr Naveed Asif, a GP at The London General Practice, spoke to the Independent, highlighting this symptom as "distinctive" for Nimbus. The NHS is also recommending that anyone who suspects they may have Covid should isolate at home. The UKHSA has issued a warning about other symptoms too: "If you have symptoms of a respiratory infection, such as COVID-19, and you have a high temperature or do not feel well enough to go to work or carry out normal activities, you should avoid contact with vulnerable people and stay at home if possible." Further advice on how to live with Covid, including what to do if unable to self-isolate, can be found on the website. First identified in January, Nimbus has been spreading globally and is now considered the dominant strain in China and accounts for a third of cases in the US. It is thought to be the driving factor behind a new surge of cases in Australia. A recent preprint study indicates that the Nimbus variant binds more efficiently to human cells. This may allow for easier transmission and raise the possibility of it bypassing the immunity that most of the population has gained from previous infections. The research surrounding Nimbus has yet to undergo peer review. However, it's worth noting that the WHO has stated that existing Covid vaccines are effective against this new strain. Salon reports there is no evidence at this stage suggesting that Nimbus leads to more severe illness than other Covid variants. Dr. T. Ryan Gregory, a researcher from the University of Guelph in Canada, expressed caution to the publication: "That said, we learned from Omicron that high transmissibility can cause as much damage as high per infection virulence and at this point it is not just acute severity that is of concern, but longer-term impacts of repeated infection." He went on to explain to Salon that identifying specific symptoms unique to the Nimbus variant could be challenging due to the presence of multiple variants and that testing levels are presently lower than they were during peak periods of the pandemic. Last week, Dr Gayatri Amirthalingam, UKHSA deputy director, announced: "NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid cases. "Based on the available information so far however, there is no evidence to suggest that this variant causes more severe disease than previous variants, or that the vaccines in current use will be less effective against it."
